She showed clinical and radiological evidence of a response to treatment with nebulised and intravenous ribavirin and intravenous pooled normal human immunoglobulin
1997 Feb;99(2):261-7
Patients in the experimental group received intravenous ribavirin versus supportive care only in the control group
Ribavirin is licensed in aerosol form for the treatment of respiratory syncytial virus infection, and orally in combination with interferon to treat hepatitis C
Intravenous Ribavirin for Parainfluenza and Respiratory Syncytial Virus in an Infant Receiving Extracorporeal Membrane Oxygenation and Continuous Renal Replacement
Intravenous ribavirin can, however, be authorized for use as a result of an Emergency Investigational New Drug (EIND) application as investigational treatment for
Ribavirin, a nucleotide analogue, is the only antiviral drug approved by the Federal Drug Administration (FDA) for treatment of RSV disease
Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation
Background: Intravenous (IV) ribavirin is not approved in US and European Union, but it is authorized in China
Background: Intravenous (IV) ribavirin is not approved in US and European Union, but it is authorized in China
The Food and Drug Administration (FDA) grants EINDs on a case-by-case basis
Only 2 of the 10 survived (20%; 95% CI, 3-56)
Ribavirin dosages according to weight: Less than 47 kg: 15 mg/kg (oral solution) orally per day in 2 divided doses
Ribavirin remains an approved option for viral infections worldwide, including those without specific antiviral drugs, due to its broad antiviral activity ( 29 )
Results: Twenty
Authors Osemwegie E Bolivian hemorrhagic fever (BHF) is a potentially severe febrile illness caused by Machupo virus (family Arenaviridae)
Methods: RSV was identified in nasopharyngeal and throat swabs (NPS) using indirect fluorescent Abstract
It is not known if treatment that includes ribavirin and another medication cures hepatitis C infection, prevents liver damage that may be caused by hepatitis C, or prevents the Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin Br J Haematol
Active substance
2 to 1 μg/mL (in this